Zymeworks Total Assets 2016-2022 | ZYME
Zymeworks total assets from 2016 to 2022. Total assets can be defined as the sum of all assets on a company's balance sheet.
Zymeworks Annual Total Assets (Millions of US $) |
2021 |
$389 |
2020 |
$538 |
2019 |
$368 |
2018 |
$244 |
2017 |
$132 |
2016 |
$94 |
2015 |
$23 |
Zymeworks Quarterly Total Assets (Millions of US $) |
2022-06-30 |
$369 |
2022-03-31 |
$430 |
2021-12-31 |
$389 |
2021-09-30 |
$420 |
2021-06-30 |
$472 |
2021-03-31 |
$490 |
2020-12-31 |
$538 |
2020-09-30 |
$572 |
2020-06-30 |
$607 |
2020-03-31 |
$637 |
2019-12-31 |
$368 |
2019-09-30 |
$400 |
2019-06-30 |
$415 |
2019-03-31 |
$238 |
2018-12-31 |
$244 |
2018-09-30 |
$194 |
2018-06-30 |
$211 |
2018-03-31 |
$114 |
2017-12-31 |
$132 |
2017-09-30 |
$100 |
2017-06-30 |
$115 |
2017-03-31 |
$80 |
2016-12-31 |
$94 |
2016-09-30 |
$0 |
2016-06-30 |
$0 |
2016-03-31 |
$0 |
2015-12-31 |
$23 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.561B |
$0.412B |
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
|